DNA X, Inc.

NasdaqCM:SONM Stock Report

Market Cap: US$7.1m

DNA X Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for DNA X.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Tech earnings growth11.8%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Analysis Article May 08

Sonim Technologies, Inc.'s (NASDAQ:SONM) Profit Outlook

Sonim Technologies, Inc. ( NASDAQ:SONM ) is possibly approaching a major achievement in its business, so we would like...

Recent updates

Analysis Article Feb 15

Little Excitement Around Sonim Technologies, Inc.'s (NASDAQ:SONM) Revenues As Shares Take 31% Pounding

Sonim Technologies, Inc. ( NASDAQ:SONM ) shareholders won't be pleased to see that the share price has had a very rough...
Analysis Article Oct 25

Market Might Still Lack Some Conviction On Sonim Technologies, Inc. (NASDAQ:SONM) Even After 26% Share Price Boost

Sonim Technologies, Inc. ( NASDAQ:SONM ) shares have had a really impressive month, gaining 26% after a shaky period...
Analysis Article Aug 07

Lacklustre Performance Is Driving Sonim Technologies, Inc.'s (NASDAQ:SONM) 47% Price Drop

Sonim Technologies, Inc. ( NASDAQ:SONM ) shareholders that were waiting for something to happen have been dealt a blow...
Analysis Article Jun 14

Sonim Technologies, Inc. (NASDAQ:SONM) Shares Fly 27% But Investors Aren't Buying For Growth

Sonim Technologies, Inc. ( NASDAQ:SONM ) shares have had a really impressive month, gaining 27% after a shaky period...
Analysis Article Mar 29

Sonim Technologies, Inc. (NASDAQ:SONM) Might Not Be As Mispriced As It Looks

You may think that with a price-to-sales (or "P/S") ratio of 0.3x Sonim Technologies, Inc. ( NASDAQ:SONM ) is a stock...
Analysis Article Feb 02

Sonim Technologies (NASDAQ:SONM) Might Be Having Difficulty Using Its Capital Effectively

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Analysis Article Nov 03

Is Sonim Technologies (NASDAQ:SONM) In A Good Position To Invest In Growth?

We can readily understand why investors are attracted to unprofitable companies. For example, although...
Analysis Article Sep 17

Take Care Before Diving Into The Deep End On Sonim Technologies, Inc. (NASDAQ:SONM)

With a price-to-sales (or "P/S") ratio of 0.3x Sonim Technologies, Inc. ( NASDAQ:SONM ) may be sending bullish signals...
Seeking Alpha Oct 07

Sonim technologies launches xp5plus rugged device with TELUS

Sonim Technologies (NASDAQ:SONM) has announced the availability of the XP5plus for TELUS customers in Canada. Sonim Technologies Launches XP5plus Rugged Device with TELUS. The XP5plus builds on the legacy of its predecessor, the XP5s, one of the most widely used PTT-over-Cellular ultra-rugged devices among frontline workers and first responders who need instant reliable two-way communications when it matters most. The new XP5plus is purpose-built for critical communications and includes features that enhance the Push-to-Talk (PTT) experience including optional top-mount control knobs for channel selection and volume control, that provide improved situational awareness. With the XP5plus, PTT can now be accessed without users ever taking their eyes off the mission in front of them. Company are pleased to expand the availability of the XP5plus across Canada," said Peter Liu, CEO, Sonim Technologies. Source: Press Release
Seeking Alpha Sep 06

Sonim technologies climbs 4.98% on securing $9M tablet purchase order

Sonim Technologies (NASDAQ:SONM) gains 4.98% premarket on securing $9M tablet purchase order for products designed by Sonim and assembled via an ODM relationship. The company expects to ship the initial purchase order starting from the Q3, then fulfill additional orders in late 2022 and throughout 2023. The new tablet order exemplifies the company's strategic plans to enter the larger and more diverse industrial equipment market with new devices leveraging its engineering expertise and rugged heritage. The tablet is an ODM project for which the company will design and build the devices for shipment to U.S. carrier partners. The tablet targets both enterprise and consumer applications, including service and education applications.
Seeking Alpha Aug 12

Sonim Technologies GAAP EPS of -$0.22, revenue of $11.96M

Sonim Technologies press release (NASDAQ:SONM): Q2 GAAP EPS of -$0.22. Revenue of $11.96M (+0.1% Y/Y). Shares +6.33% PM.
Analysis Article Jul 05

We're Keeping An Eye On Sonim Technologies' (NASDAQ:SONM) Cash Burn Rate

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Analysis Article May 08

Sonim Technologies, Inc.'s (NASDAQ:SONM) Profit Outlook

Sonim Technologies, Inc. ( NASDAQ:SONM ) is possibly approaching a major achievement in its business, so we would like...
Analysis Article Mar 09

Reflecting on Sonim Technologies' (NASDAQ:SONM) Share Price Returns Over The Last Year

It is a pleasure to report that the Sonim Technologies, Inc. ( NASDAQ:SONM ) is up 44% in the last quarter. But that...
Analysis Article Jan 15

Should You Take Comfort From Insider Transactions At Sonim Technologies, Inc. (NASDAQ:SONM)?

It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as DNA X has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NasdaqCM:SONM - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2026N/A-11-17-17N/A
12/31/2025N/A-8-24-24N/A
9/30/2025-16-4-26-26N/A
6/30/2025-17-2-20-19N/A
3/31/2025-17-1-18-18N/A
12/31/2024N/A-3-9-8N/A
9/30/202457-13-5-4N/A
6/30/202469-10-4-4N/A
3/31/202485-300N/A
12/31/2023940-4-4N/A
9/30/20231040-6-6N/A
6/30/202397-2-16-16N/A
3/31/202382-7-16-16N/A
12/31/202270-14-12-12N/A
9/30/202262-25-28-28N/A
6/30/202256-34-23-23N/A
3/31/202256-37-31-31N/A
12/31/202155-39-39-38N/A
9/30/202154-33-31-31N/A
6/30/202154-29-31-31N/A
3/31/202164-29-20-20N/A
12/31/202064-30-11-11N/A
9/30/202065-32-6-5N/A
6/30/202080-3267N/A
3/31/2020102-31-29-28N/A
12/31/2019116-26N/A-34N/A
9/30/2019146-14N/A-23N/A
6/30/2019156-8N/A-26N/A
3/31/2019144-6N/A4N/A
12/31/2018136-9N/A4N/A
12/31/201759-15N/A-9N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if SONM's forecast earnings growth is above the savings rate (3.5%).

Earnings vs Market: Insufficient data to determine if SONM's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if SONM's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if SONM's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if SONM's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SONM's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/14 14:44
End of Day Share Price 2026/06/12 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DNA X, Inc. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael CrawfordB. Riley Securities, Inc.
Jaeson Allen SchmidtLake Street Capital Markets, LLC
Zhihua YangOppenheimer & Co. Inc.